Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-09-09FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for tamsulosin hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2019-09-09FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for tamsulosin hydrochloride by Zydus Lifesciences Limited, enabling the generic product to be marke…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study [Phase 2]
A Phase 2 randomized trial investigates mirabegron for erectile dysfunction in men with lower urinary tract symptoms due to BPH; current sta…
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH [Phase 3]
A Phase 3 trial comparing solifenacin/tamsulosin combination therapy to tamsulosin alone for lower urinary tract symptoms due to benign pros…
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years [Phase 4]
Phase 4 clinical trial update on a screening tool for benign prostatic hyperplasia in subjects aged 50 and older; study completed with poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCT [Phase 4]
Phase 4 randomized trial comparing GreenLight laser photoselective vaporization of the prostate to bipolar transurethral vaporization in men…
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: A Study in Men With Benign Prostatic Hyperplasia [Phase 2]
A Phase 2 study in men with benign prostatic hyperplasia (BPH) was terminated; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia [Phase 3]
Phase 3 trial comparing dutasteride–tamsulosin combination therapy to tamsulosin alone for moderate to severe benign prostatic hyperplasia h…
-
FDA approval · 2019-03-29FDA Approved: TADALAFIL — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's tadalafil generic (ANDA 205885) under Original Application. The product is indicated for erectile dysfunction and benign…
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal's generic tadalafil tablets under an original ANDA, making a generic tadalafil available for erectile dysfunction and be…
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved an Original Application (ANDA) for tadalafil submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves Zydus Pharmaceuticals USA Inc.'s generic tadalafil (TADALAFIL) for Erectile Dysfunction and Benign Prostatic Hyperplasia under …
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's original application for tadalafil as a generic drug. The approval covers indications for…
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (Aurobindo Pharma Limited)
The FDA approved the original ANDA for tadalafil from Aurobindo Pharma Limited, enabling a generic version of tadalafil to be marketed in th…
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original application for tadalafil from Unichem Pharmaceuticals (USA), Inc., authorizing a generic tadalafil product for th…
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (NorthStar RxLLC)
FDA approved a tadalafil generic by NorthStar RxLLC via an Original Application (ANDA208934) for erectile dysfunction and benign prostatic h…
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (Dr.Reddys Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' original application for tadalafil, a generic version of the erectile dysfunction medication Cialis.
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved a generic tadalafil (TADALAFIL) from Qilu Pharmaceutical Co., Ltd. under an original ANDA.
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (HEC Pharm USA Inc.)
FDA approves the original ANDA for tadalafil by HEC Pharm USA Inc., enabling a generic tadalafil product. It covers indications commonly ass…
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for generic tadalafil (Tadalafil) for erectile dysfunction and benign prostatic h…
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's generic tadalafil tablet under an Original Application (ANDA).
-
FDA approval · 2019-03-26FDA Approved: TADALAFIL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic tadalafil under an Original Application (ANDA 209908). The approval covers tadalafil for erecti…
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Randomized Controlled Trial Comparing Two Different Morcellators for HoLEP Procedures [NA]
Clinical trial comparing two morcellators for HoLEP procedures completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Benign Prostatic Hyperplasia and Ischemic Heart DIsease [Phase 4]
Phase 4 clinical trial update for Benign Prostatic Hyperplasia and Ischaemic Heart Disease completed.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Study of Median Lobe Prostatic UroLift Procedure [NA]
Clinical trial update for the UroLift procedure in benign prostatic hyperplasia has completed with results posted.